Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Patients with cancer face difficult decisions when it comes to their healthcare. From diagnosis to treatment and beyond, there are many overwhelming decisions to make.
Advance directives are a powerful way to take control of healthcare choices. These documents allow you to outline preferences for medical care and specify end-of-life wishes. These documents can also be a way to appoint loved ones who you would like to help with these decisions, such as a healthcare proxy (someone to make decisions on your behalf, if you cannot). As cancer treatments can involve aggressive treatments and/or complex medical management, having advance directives ensures that your desires regarding treatment options and end-of-life care are clearly communicated.
Living Will: These are legal documents that address what treatments you would (or would not) want to be used to keep you alive. These can include decisions about chemotherapy, radiation, or surgery. A living will can also be a way to outline your preferences about pain management and end-of-life care and can address things like:
Health Care Proxy (HCP) (or Agent): This is a person you can designate to ensure your wishes are followed, even if you yourself cannot voice them. Your proxy should know your wishes about the above interventions.
Do Not Resuscitate (DNR) Order: Some patients with serious illnesses choose to have a DNR order in place, meaning they would not wish for CPR. They instead opt for a natural death if their heart stops beating.
Physician Orders for Life-Sustaining Treatment (POLST): Many states now have these (often brightly colored) forms that document wishes about the above interventions (CPR, mechanical ventilation, hospitalization, dialysis, etc.) as discussed between patients and their medical provider. It is always signed by a medical professional and is something to have on hand in hopes that it can be used by hospitals and first responders.
Maintaining control and quality of life: Patients with cancer face difficult treatment options. By expressing preferences about treatments and end-of-life care, you can ensure your wishes are respected throughout. Treatments can directly affect quality of life; being proactive in specifying treatment preferences is one way to maintain control of your cancer therapy navigation.
Providing peace of mind: For both patients and their loved ones, there is comfort with knowing your healthcare preferences are fully documented. This can alleviate anxiety and uncertainty for family members as well. By creating advance directives, you can focus more on what matters the most to you outside of your cancer diagnosis.
American Cancer Society. (2021). “Advanced Directives.”
American Society of Clinical Oncology. (2021). “Advance Directives.”
National Cancer Institute. (2021). “Advance Directives and End-of-Life Decisions.”
National Institute on Aging. (2020). “Advance Care Planning: Healthcare Directives.”
Mayo Clinic. (2004). “Living Wills and Advance Directives for Medical Decisions.”
Please feel free to offer comments and raise questions in our
discussion forums.
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...
The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)
There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...
Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.
The...
Biomarkers are genetic mutations (like EGFR, ALK, KRAS, BRAF) or protein levels (like PD-L1) in tumor cells that help guide personalized treatment, especially NSCLC, directing patients to targeted therapies or immunotherapies...
Hi Stan! So good to hear from you. I'm sorry for the late response. I too have been out of town with family and missed your post, probably because I was...
It is so good to hear from you! And I am so happy to hear that your holidays have been good and that you are doing well. It sounds like your...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components: